Stock listing

NSE:STAR Strides Pharma Science Ltd Share Price

Home listing (NSE) of Strides Pharma Science Ltd

Follow Strides Pharma Science Ltd into a list and get an email when it puts out news.

Share price · NSE:STAR

₹967.30 INR +9.20 (+1.0%)

Close on Nov 20, 2026

Past year +4.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₹956.10 – ₹982.00 INRNov 20, 2026
Volume
232,614 sharesNov 20, 2026
Market cap
₹89.16B INRAt the close on Nov 20, 2026 · price × 92.17M shares outstanding
52-week range
₹768.65 – ₹1,260.90 INRLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₹440.7M INRMedian day 231,125 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Strides Pharma Science Ltd logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NSE:STAR · Home₹967.30 INR+9.20 (+1.0%)232,614₹982.00₹982.00₹956.10₹958.10Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:STAR · INR, adjusted for splits

DayCloseChange%OpenHighLowVolume
₹967.30+9.20+1.0%₹982.00₹982.00₹956.10232,614
₹958.10-24.00-2.4%₹983.00₹990.50₹956.70281,333
₹982.10-4.00-0.4%₹980.50₹1,000.00₹973.00238,815
₹986.10-28.50-2.8%₹1,015.00₹1,024.70₹979.70148,808
₹1,014.60+5.30+0.5%₹1,009.30₹1,020.80₹1,004.50128,959
₹1,009.30+9.90+1.0%₹1,001.00₹1,017.50₹985.10381,960
₹999.40-2.80-0.3%₹1,008.30₹1,016.00₹988.00379,125
₹1,002.20+2.60+0.3%₹1,033.10₹1,039.90₹1,000.00198,743
₹999.60-8.00-0.8%₹1,002.60₹1,009.00₹991.80186,978
₹1,007.60-6.60-0.7%₹1,025.00₹1,028.10₹993.60438,710
₹1,014.20-23.10-2.2%₹1,034.00₹1,047.80₹1,010.00184,808
₹1,037.30+0.400.0%₹1,040.00₹1,055.00₹1,010.40495,561
₹1,036.90-31.90-3.0%₹1,067.30₹1,067.30₹1,013.90407,966
₹1,068.80-28.70-2.6%₹1,050.00₹1,076.90₹972.002,677,933
₹1,097.50+11.90+1.1%₹1,087.40₹1,105.00₹1,087.40203,597
₹1,085.60-7.70-0.7%₹1,093.30₹1,109.90₹1,077.40396,024
₹1,093.30+60.20+5.8%₹1,025.50₹1,116.40₹1,025.50787,204
₹1,033.10+18.30+1.8%₹1,006.50₹1,053.90₹1,001.00281,520
₹1,014.80+16.40+1.6%₹1,000.00₹1,023.60₹980.40312,085
₹998.40-26.90-2.6%₹1,015.00₹1,029.80₹994.20223,577
₹1,025.30-4.00-0.4%₹1,021.00₹1,031.00₹1,002.70144,622
₹1,029.30-15.90-1.5%₹1,050.00₹1,050.00₹1,015.90224,715
₹1,045.20-14.70-1.4%₹1,060.00₹1,066.00₹1,040.00207,930
₹1,059.90-24.90-2.3%₹1,080.10₹1,089.20₹1,051.30253,392
₹1,084.80-10.70-1.0%₹1,087.00₹1,094.00₹1,071.70184,350
₹1,095.50-0.70-0.1%₹1,086.30₹1,107.00₹1,063.00304,227
₹1,096.20+10.90+1.0%₹1,082.00₹1,103.40₹1,080.3080,618
₹1,085.30-10.00-0.9%₹1,095.00₹1,102.20₹1,072.00189,136
₹1,095.30-5.30-0.5%₹1,100.60₹1,106.10₹1,067.00420,852
₹1,100.60+11.90+1.1%₹1,085.10₹1,109.00₹1,076.70202,258
₹1,088.70+2.00+0.2%₹1,081.20₹1,096.20₹1,074.00138,279
₹1,086.70+1.90+0.2%₹1,087.00₹1,109.90₹1,077.60108,287
₹1,084.800.000.0%₹1,084.80₹1,084.80₹1,084.800
₹1,084.80-35.20-3.1%₹1,108.40₹1,122.00₹1,076.00340,843
₹1,120.00-52.60-4.5%₹1,167.00₹1,174.50₹1,110.00447,494
₹1,172.60+21.20+1.8%₹1,143.10₹1,182.50₹1,131.00229,635
₹1,151.40-33.50-2.8%₹1,175.80₹1,186.00₹1,148.20115,834
₹1,184.90-17.90-1.5%₹1,202.80₹1,209.60₹1,177.20143,012
₹1,202.80-20.50-1.7%₹1,222.20₹1,233.10₹1,199.30126,615
₹1,223.30+5.90+0.5%₹1,217.00₹1,242.20₹1,217.00153,250
₹1,217.40-17.70-1.4%₹1,234.20₹1,246.70₹1,195.50285,056
₹1,235.10+15.30+1.3%₹1,230.00₹1,260.90₹1,217.40421,704
₹1,219.80+19.60+1.6%₹1,202.60₹1,229.40₹1,200.00282,913
₹1,200.20+16.30+1.4%₹1,180.00₹1,214.90₹1,162.00225,030
₹1,183.90+33.30+2.9%₹1,153.40₹1,192.00₹1,102.00398,309
₹1,150.60-32.80-2.8%₹1,183.00₹1,203.00₹1,127.00421,480
₹1,183.400.000.0%₹1,183.40₹1,183.40₹1,183.400
₹1,183.40-33.60-2.8%₹1,199.90₹1,215.90₹1,179.00161,625
₹1,217.00+21.30+1.8%₹1,189.00₹1,223.00₹1,159.70304,120
₹1,195.70+8.30+0.7%₹1,187.40₹1,217.00₹1,181.30376,096
₹1,187.40+8.60+0.7%₹1,169.00₹1,206.90₹1,155.30491,962
₹1,178.80+119.20+11.2%₹1,058.70₹1,187.60₹1,045.002,617,272
₹1,059.60+6.00+0.6%₹1,053.10₹1,066.50₹1,040.00217,190
₹1,053.60+5.80+0.6%₹1,053.90₹1,073.00₹1,043.10189,318
₹1,047.80+23.60+2.3%₹1,009.40₹1,050.10₹1,009.40327,406
₹1,024.20-0.80-0.1%₹1,025.00₹1,030.00₹1,010.00200,361
₹1,025.00+5.10+0.5%₹1,029.00₹1,038.10₹1,006.90426,871
₹1,019.90+36.90+3.8%₹984.00₹1,026.50₹982.10435,651
₹983.00+0.100.0%₹982.90₹994.40₹978.9094,124
₹982.90-3.70-0.4%₹986.60₹999.40₹981.0097,630
₹986.60-7.00-0.7%₹999.00₹1,001.90₹976.00209,006
₹993.60+7.40+0.8%₹989.40₹999.00₹974.30220,560
₹986.20-6.80-0.7%₹998.00₹1,003.00₹970.60341,043
₹993.00+35.50+3.7%₹986.50₹1,056.00₹970.004,948,966
Ticker
NSE:STAR
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
NSE
Currency
INR

What changed lately

Latest news

All Strides Pharma Science Ltd news

Strides Pharma Science Ltd on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
10 in the last 12 months · 110 in all · newest Oct 29, 2026 · oldest 2020
Decks
31 decks · latest Oct 29, 2026

Where Strides Pharma Science Ltd is listed

ListingExchangeCountryCurrency
NSE:STAR · Home listing · This pageNSEIndiaINR
BSE:STARBSEIndiaINR

Valuation

P/E 14.5× against a median of 24.4×: the lowest of 8 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
₹105.1B INR
P/E
14.5×
EV/sales
2.0×
EV/EBITDA
11.0×
Price/book
2.6×
Gross margin
42.4%
Operating margin
14.2%
Net margin
11.8%
Debt to equity
0.6×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Strides Pharma Science Ltd · NSE:STARUS$962.1MUS$1.13B14.5×2.0×11.0×2.6×11.8%0.6×n/a
Beijing Foyou Pharma Co., Ltd. Class A · SSE:601089US$1.03BUS$709.2M18.7×1.3×n/a1.8×10.2%0.0×n/a
Chengdu Easton Biopharmaceuticals Co., Ltd. Class A · SSE:688513US$994.9MUS$735.9M24.4×3.8×n/a2.2×20.9%0.0×n/a
Jiangsu Kanion Pharmaceutical Co. Ltd. Class A · SSE:600557US$981.0MUS$675.6M20.8×1.3×n/a1.3×9.4%0.0×n/a
Aarti Pharmalabs Limited · NSE:AARTIPHARMUS$969.4MUS$1.04B35.0×4.5×19.4×4.0×11.9%0.3×n/a
CanSino Biologics, Inc. Class A · SSE:688185US$943.8MUS$802.4M226×5.0×26.7×1.3×2.6%0.2×n/a
Zhejiang Tianyu Pharmaceutical Co. Ltd. Class A · SZSE:300702US$941.2MUS$934.7M90.7×1.6×n/a1.7×1.8%0.1×n/a
Chongqing Taiji Industry (Group) Co., Ltd. Class A · SSE:600129US$937.3MUS$910.3Mn/a0.6×n/a1.8×−0.2%0.1×n/a
Jiangxi Fushine Pharmaceutical Co., Ltd. Class A · SZSE:300497US$928.5MUS$955.4M14.8×3.3×n/a2.4×21.2%0.3×n/a
KPC Pharmaceuticals, Inc. Class A · SSE:600422US$919.4MUS$815.3Mn/a1.2×n/a1.3×−6.3%0.1×n/a
Changchun BCHT Biotechnology Co. Class A · SSE:688276US$906.3MUS$882.1Mn/a8.7×n/a1.6×−30.8%0.0×n/a
Median of the othersUS$942.5MUS$848.7M24.4×2.5×23.0×1.8×6.0%0.1×

Forecasts

Analysts' consensus from EODHD, read Nov 9, 2026. Not 6ix's view and not investment advice.

Price target
1338.67 INR · Analysts' mean
EPS, year to Mar 2027
60.30 · 1 analyst
Revenue, year to Mar 2027
57.01B · 1 analyst

Team and board

Officers

OfficerRole
Badree KomandurMD & Group CEO
Ramaraju PVSExecutive Director

Board

DirectorRole
Arun KumarNon-Executive Chairperson
Aditya Arun KumarNon-Executive Director
Ameet P HarianiIndependent Director
Badree KomandurMD & Group CEO
Biren GabhawalaIndependent Director
Homi Rustam KhusrokhanIndependent Director
Kausalya SanthanamIndependent Director
Mukta AroraIndependent Director
Ramaraju PVSExecutive Director
Subir ChakrabortyIndependent Director

Events

QuarterResultsShare move
Q4 2024May 22, 2024 · After close−3.0%
Q3 2023Jan 24, 2023 · Before open−5.4%
Q2 2023Nov 14, 2022 · Before open+8.1%
Q1 2023Jul 29, 2022 · Before open−0.9%
Q4 2022May 24, 2022 · Before open−1.4%
Q3 2022Feb 10, 2022 · Before open−1.1%
Quarter to Sep 30, 2021Nov 10, 2021 · Before open−8.6%
Quarter to Jun 30, 2021Aug 6, 2021 · Before open−6.3%
Quarter to Mar 31, 2021May 27, 2021−2.2%
Quarter to Dec 31, 2020Feb 4, 2021 · Before open−0.9%

Open Events

Decks

DeckKindSlidesDate
Q2 FY2027 Earnings PresentationEarnings23 slidesOct 29, 2026
Q2 FY27 Earnings PresentationEarnings22 slidesOct 29, 2026
Q1 FY2027 Earnings PresentationEarnings16 slidesJul 31, 2026
Q4 FY2026 Earnings PresentationEarnings23 slidesMay 18, 2026
Q4 FY26 Earnings PresentationEarnings20 slidesMay 18, 2026
Q3 FY2026 Earnings PresentationEarnings22 slidesJan 30, 2026
Q3 FY2026 Earnings PresentationEarnings19 slidesJan 30, 2026
Shareholder Meeting (August 2025)Shareholder meeting15 slidesAug 7, 2025
Q1 FY2026 Earnings PresentationEarnings17 slidesAug 7, 2025
Q2 FY2025 Earnings PresentationEarnings27 slidesOct 24, 2024
All 31 decks
DeckKindSlidesDate
Q1 FY2025 Earnings PresentationEarnings23 slidesJul 29, 2024
Investor Presentation (February 2024)Investor deck48 slidesFeb 2, 2024
Investor Presentation (February 2024)Investor deck47 slidesFebruary 2024
Shareholder Meeting (February 2023)Shareholder meeting6 slidesFeb 6, 2023
Q3 FY2023 Earnings PresentationEarnings13 slidesJan 24, 2023
Q2 FY2023 Earnings PresentationEarnings18 slidesNov 14, 2022
Shareholder Meeting (September 2022)Shareholder meeting11 slidesSeptember 2022
Q1 FY2023 Earnings PresentationEarnings18 slidesJul 29, 2022
Q4 FY2022 Earnings PresentationEarnings18 slidesMay 24, 2022
Shareholder Meeting (April 2022)Shareholder meeting5 slidesApr 7, 2022
Q3 FY2022 Earnings PresentationEarnings15 slidesFeb 10, 2022
Q2 FY2022 Earnings PresentationEarnings23 slidesNov 10, 2021
Shareholder Meeting (September 2021)Shareholder meeting21 slidesSep 3, 2021
Investor Presentation (September 2021)Investor deck37 slidesSeptember 2021
Q1 FY2022 Earnings PresentationEarnings15 slidesAug 6, 2021
Stelis Biopharma — Q1 FY22 Earnings PresentationEarnings21 slidesAug 6, 2021
Q1 FY2021 Earnings PresentationEarnings17 slidesAug 5, 2020
Investor Day (December 2019)Investor day86 slidesDec 5, 2019
Investor Presentation (November 2018)Investor deck28 slidesNovember 2018
Strides Arcolab — Merger or Acquisition (September 2014)Merger or acquisition17 slidesSep 30, 2014
Strides Arcolab — Merger or Acquisition (January 2012)Merger or acquisition10 slidesJan 24, 2012

Open Decks

Financials

Annual, in INR

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue48.6B44.8B38.3B36.7B30.6B32.8B26.8B21.2B28.5B27.6B
Cost of revenue30.9B32.9B29.8B28.6B26.5B23.2B19.7B16.9B21.5B18.4B
Gross profit17.7B11.8B8.51B8.05B4.11B9.59B7.12B4.27B6.93B9.13B
Research and development679.3M595.4M638.6M893.9M1.06B1.04B1.29B1.19B1.58B
Selling, general and administrative4.97B8.78B1.56B7.46B1.51B1.15B1.15B1.06B945.0M1.02B
Operating income7.23B5.18B3.02B1.24B-2.52B3.15B1.89B855.1M2.56B4.03B
Depreciation and amortization2.02B1.92B2.21B2.43B2.33B2.06B1.88B1.72B1.50B1.26B
EBITDA9.25B7.11B5.23B3.67B-189.4M5.21B3.76B2.57B4.06B5.30B
Interest expense1.79B2.49B2.80B2.61B1.77B1.50B1.55B789.7M1.96B1.83B
Income before tax6.69B4.87B-1.15B-2.86B-6.53B2.75B546.8M624.0M799.5M3.43B
Income tax941.7M775.2M291.1M-553.0M-1.78B316.5M113.2M-268.6M56.9M634.0M
Net income5.56B4.05B-1.20B-2.21B-4.60B2.55B241.5M523.1M-457.9M1.81B
Earnings per share, basic60.3444.05-13.19-24.55-51.2828.372.705.84-5.1220.24

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents2.13B1.37B1.61B3.04B1.71B1.26B1.82B3.66B2.56B3.22B
Short-term investments157.9M860.6M1.29B572.0M134.6M1.49B1.66B4.27B3.52B12.9B
Receivables13.0B12.0B11.4B14.1B18.0B11.5B-25.8M-34.6M9.75B10.0B
Inventory16.3B12.8B11.3B11.5B11.7B12.0B7.83B8.71B5.52B7.38B
Current assets36.1B31.0B29.7B32.4B33.6B28.2B23.7B30.5B24.9B38.2B
Property, plant and equipment15.1B15.0B14.6B11.4B9.87B11.8B
Goodwill5.94B5.47B5.29B5.14B4.86B4.81B4.29B13.7B9.15B9.67B
Total assets69.3B60.5B58.4B66.4B69.8B70.2B61.5B80.1B65.4B81.2B
Accounts payable13.1B10.3B8.52B9.82B10.7B11.3B7.98B8.89B7.12B7.74B
Current liabilities29.0B25.9B28.8B29.9B34.1B27.4B25.4B27.0B19.0B30.4B
Long-term debt5.52B5.71B6.71B11.4B8.36B8.83B6.04B18.1B15.5B16.3B
Total debt17.6B18.8B25.2B30.3B30.3B23.5B22.3B32.3B25.3B37.3B
Total liabilities37.8B34.6B37.7B44.7B45.9B42.0B35.6B52.0B39.3B52.4B
Shareholders' equity31.1B25.5B21.3B22.1B23.6B27.8B25.3B26.5B24.5B27.1B
Shares outstanding92.2M92.0M91.1M90.1M89.7M89.7M89.6M89.6M89.5M89.5M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations5.39B6.84B7.01B444.1M-2.58B4.81B2.05B600.5M1.87B2.88B
Capital spending-4.18B-2.42B-1.18B-949.4M-1.43B-2.97B-1.50B-3.29B-4.03B-6.82B
Free cash flow1.21B4.42B5.83B-505.3M-4.01B1.84B547.9M-2.69B-2.16B-3.94B
Cash from investing-1.78B-896.9M-1.50B3.02B-1.19B-5.21B13.1B-1.48B5.83B-7.05B
Cash from financing-2.85B-6.43B-6.93B-2.14B4.21B-158.0M-17.1B1.94B-10.2B3.38B
Dividends paid-368.6M-229.9M-135.2M-224.3M-179.2M-1.54B-179.5M-442.9M-357.5M
Share buybacks3.91B-1.82B2.38B12.3B10.3B
Change in cash929.2M-484.6M-1.42B1.33B449.0M-564.0M-1.84B1.10B-2.59B-5.96B

Open Financials

Filings

FilingDateTypeFiled with
Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 29, 2026, titled "Strides Delivers Strong Performance with Q2FY27 Revenue at ₹14,297m, Grew 17% YoYEx-US Markets Up 31% YoY; EBITDA Up 8% YoY to ₹2,509m, Crossing ₹2,500m in a Quarter for the First Time".Oct 29, 2026ResultsNSE India
Strides Pharma Science Ltd Press Release Aug 19 2026Aug 19, 2026Other filingsNSE India
Strides Pharma Science Ltd Press Release Jul 31 2026Jul 31, 2026ResultsNSE India
Strides Pharma Science Ltd Press Release Jun 27 2026Jun 27, 2026Operations updateNSE India
Press Release May 18 2026May 18, 2026ResultsNSE India
Press Release Mar 17 2026Mar 17, 2026Acquisition or disposalNSE India
Press Release Feb 05 2026Feb 5, 2026Other filingsNSE India
Strides Pharma Science Ltd Press Release Feb 05 2026Feb 4, 2026Other filingsNSE India
Press Release Jan 30 2026Jan 30, 2026ResultsNSE India
Press Release Oct 31 2025Oct 31, 2025ResultsNSE India
All 87 filings
FilingDateTypeFiled with
Press Release Oct 17 2025Oct 17, 2025Other filingsNSE India
Press Release Sep 08 2025Sep 8, 2025Operations updateNSE India
Press Release Jul 29 2025Jul 29, 2025ResultsNSE India
Press Release May 22 2025May 22, 2025ResultsNSE India
Press Release Apr 30 2025Apr 30, 2025Operations updateNSE India
Press Release Jan 30 2025Jan 30, 2025ResultsNSE India
Press Release Jan 20 2025Jan 20, 2025Other filingsNSE India
Press Release Oct 24 2024Oct 24, 2024Quarterly reportNSE India
Strides Pharma Science Ltd Press Release Oct 16 2024Oct 15, 2024Other filingsNSE India
Press Release Sep 16 2024Sep 16, 2024Other filingsNSE India
Press Release Sep 11 2024Sep 11, 2024Operations updateNSE India
Press Release Sep 06 2024Sep 6, 2024Other filingsNSE India
Press Release May 22 2024May 22, 2024ResultsNSE India
Press Release May 10 2024May 10, 2024Other filingsNSE India
Strides Pharma Science Ltd Press Release Apr 09 2024Apr 8, 2024Operations updateNSE India
Press Release Mar 05 2024Mar 5, 2024Other filingsNSE India
Press Release Jan 30 2024Jan 30, 2024ResultsNSE India
Press Release Jan 25 2024Jan 25, 2024Operations updateNSE India
Press Release Dec 01 2023Dec 1, 2023Operations updateNSE India
Strides Pharma Science Ltd Press Release Nov 23 2023Nov 22, 2023Operations updateNSE India
Press Release Nov 21 2023Nov 21, 2023Operations updateNSE India
Press Release Oct 30 2023Oct 30, 2023ResultsNSE India
Press Release Oct 04 2023Oct 4, 2023Operations updateNSE India
Press Release (Revised) Oct 03 2023Oct 3, 2023Other filingsNSE India
Press Release Sep 23 2023Sep 23, 2023Operations updateNSE India
Press Release Sep 14 2023Sep 14, 2023Operations updateNSE India
Press Release Sep 09 2023Sep 9, 2023Operations updateNSE India
Press Release Aug 30 2023Aug 30, 2023Other filingsNSE India
Press Release Aug 02 2023Aug 2, 2023ResultsNSE India
Press Release Jul 04 2023Jul 4, 2023Other filingsNSE India
Press Release May 25 2023May 25, 2023ResultsNSE India
Strides Pharma Science Ltd Press Release May 19 2023May 18, 2023Legal or regulatory actionNSE India
Strides Pharma Science Ltd Press Release May 03 2023May 2, 2023Operations updateNSE India
Strides Pharma Science Ltd Press Release Feb 24 2023Feb 23, 2023Operations updateNSE India
Press Release Jan 20 2023Jan 20, 2023Operations updateNSE India
Strides Pharma Science Ltd Press Release Jan 18 2023Jan 17, 2023Other filingsNSE India
Press Release Dec 28 2022Dec 28, 2022Other filingsNSE India
Press Release Dec 22 2022Dec 22, 2022Acquisition or disposalNSE India
Press Release Nov 18 2022Nov 18, 2022Operations updateNSE India
Press Release Nov 14 2022Nov 14, 2022Other filingsNSE India
Press Release Sep 01 2022Sep 1, 2022Operations updateNSE India
Press Release Aug 26 2022Aug 26, 2022Other filingsNSE India
Press Release Aug 18 2022Aug 18, 2022Operations updateNSE India
Press Release Aug 08 2022Aug 8, 2022Other filingsNSE India
Press Release Aug 03 2022Aug 3, 2022Operations updateNSE India
Press Release Jun 24 2022Jun 24, 2022Other filingsNSE India
Press Release Jun 16 2022Jun 16, 2022Other filingsNSE India
Press Release Jun 10 2022Jun 10, 2022Operations updateNSE India
Press Release May 30 2022May 30, 2022Operations updateNSE India
Press Release May 15 2022May 15, 2022Other filingsNSE India
Press Release Mar 21 2022Mar 21, 2022Other filingsNSE India
Press Release Mar 17 2022Mar 17, 2022Other filingsNSE India
Press Release Mar 11 2022Mar 11, 2022Operations updateNSE India
Press Release Feb 21 2022Feb 21, 2022Operations updateNSE India
Press Release Jan 20 2022Jan 20, 2022Other filingsNSE India
Press Release Jan 17 2022Jan 17, 2022Operations updateNSE India
Press Release Dec 28 2021Dec 28, 2021Other filingsNSE India
Press Release Aug 06 2021Aug 6, 2021Other filingsNSE India
Press Release Jun 28 2021Jun 28, 2021Operations updateNSE India
Press Release Jun 14 2021Jun 14, 2021Operations updateNSE India
Press Release May 27 2021May 27, 2021Other filingsNSE India
Press Release Mar 19 2021Mar 19, 2021Other filingsNSE India
Press Release Mar 15 2021Mar 15, 2021Operations updateNSE India
Press Release Feb 24 2021Feb 24, 2021Other filingsNSE India
Press Release Feb 12 2021Feb 12, 2021Operations updateNSE India
Press Release Feb 04 2021Feb 4, 2021Other filingsNSE India
Press Release Jan 25 2021Jan 25, 2021Operations updateNSE India
Press Release Jan 15 2021Jan 15, 2021Other filingsNSE India
Press Release Jan 08 2021Jan 8, 2021Management or board changeNSE India
Press Release Dec 18 2020Dec 18, 2020Operations updateNSE India
Press Release Nov 23 2020Nov 23, 2020Operations updateNSE India
Press Release Oct 20 2020Oct 20, 2020Operations updateNSE India
Press Release Sep 22 2020Sep 22, 2020Other filingsNSE India
Press Release Sep 14 2020Sep 14, 2020Operations updateNSE India
Press Release Sep 03 2020Sep 3, 2020Operations updateNSE India
Press Release Aug 21 2020Aug 21, 2020Operations updateNSE India
Press Release Aug 19 2020Aug 19, 2020Other filingsNSE India

Open Filings

Cap table

Built by 6ix from Strides Pharma Science Ltd’s releases

Common shares
92,172,714
Fully diluted
92,172,714

Fully diluted

LineShares
Common shares92,172,714

Share count over time

CountShares
Nov 22, 202692,172,714

Open Cap table

Shareholders

HolderSharesValueAs of
iShares Core MSCI Emerging Markets ETF1.03MUS$12.1MMay 31, 2026
Vanguard Total International Stock Index Fund910KUS$9.77MJul 31, 2026
Vanguard Emerging Markets Stock Index Fund851KUS$9.14MJul 31, 2026
Emerging Markets Core Equity 2 Portfolio378KUS$4.08MJul 31, 2026
State Street(R) SPDR(R) Portfolio Emerging Markets ETF338KUS$3.9MJun 30, 2026
Avantis Emerging Markets Equity ETF330KUS$3.86MMay 31, 2026
Dimensional Emerging Markets Value Fund312KUS$3.37MJul 31, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund233KUS$2.5MJul 31, 2026
iShares Core MSCI Total International Stock ETF232KUS$2.5MJul 31, 2026
The Emerging Markets Small Cap Series141KUS$1.53MJul 31, 2026
All 43 holders
HolderSharesValueAs of
Dimensional Emerging Markets Core Equity 2 ETF127KUS$1.36MJul 31, 2026
Driehaus Emerging Markets Small Cap Growth Fund124KUS$1.43MJun 30, 2026
iShares MSCI India Small-Cap ETF107KUS$1.25MMay 31, 2026
LSV Emerging Markets Equity Fund88,800US$954KJul 31, 2026
Dimensional Emerging Core Equity Market ETF65,738US$706KJul 31, 2026
Sbh Emerging Markets Fund55,860US$646KJun 30, 2026
WisdomTree India Earnings Fund50,080US$578KJun 30, 2026
Vanguard Total World Stock Index Fund46,763US$502KJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF46,144US$496KJul 31, 2026
Victory Emerging Markets Fund45,502US$532KMay 31, 2026
College Retirement Equities Fund - Total Global Stock Account44,598US$515KJun 30, 2026
Fidelity Total International Index Fund42,735US$459KJul 31, 2026
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF41,595US$480KJun 30, 2026
Emerging Markets Social Core Equity Portfolio29,185US$315KJul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio26,243US$303KJun 30, 2026
Victory Capital Growth Fund24,857US$267KJul 31, 2026
World ex U.S. Core Equity Portfolio19,528US$211KJul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio17,020US$184KJul 31, 2026
Emerging Markets ex China Core Equity Portfolio16,601US$179KJul 31, 2026
State Street(R) SPDR(R) S&P(R) Emerging Asia Pacific ETF15,815US$183KJun 30, 2026
Avantis Emerging Markets Value ETF15,628US$183KMay 31, 2026
Emerging Markets Targeted Value Portfolio13,715US$148KJul 31, 2026
iShares MSCI Emerging Markets Small-Cap ETF12,108US$142KMay 31, 2026
Vanguard ESG International Stock ETF10,999US$129KMay 31, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF9,654US$104KJul 31, 2026
World ex U.S. Targeted Value Portfolio8,765US$94,627Jul 31, 2026
Dimensional Emerging Markets Value ETF8,279US$88,938Jul 31, 2026
Avantis Emerging Markets ex-China Equity ETF5,349US$62,566May 31, 2026
Avantis Responsible Emerging Markets Equity ETF3,755US$43,921May 31, 2026
Dimensional World ex U.S. Sustainability Targeted Value Portfolio3,333US$35,983Jul 31, 2026
Dimensional Emerging Markets ex China Core Equity ETF3,186US$34,226Jul 31, 2026
SA Emerging Markets Value Fund3,173US$36,370Jun 30, 2026
Avantis Emerging Markets Small Cap Equity ETF2,992US$34,996May 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Aditya Arun KumarNon-Executive Director · Since at least Sep 9, 2025
Ameet P HarianiIndependent Director · Since at least Nov 4, 2026
Arun KumarNon-Executive Chairperson · Since at least Nov 6, 2026
Badree KomandurMD & Group CEO · Since at least Nov 6, 2026
Biren GabhawalaIndependent Director · Since at least Nov 4, 2026
Homi Rustam KhusrokhanIndependent Director · Since at least Nov 4, 2026
Kausalya SanthanamIndependent Director · Since at least Nov 4, 2026
Mukta AroraIndependent Director · Since at least Nov 4, 2026
Ramaraju PVSExecutive Director · Since at least Nov 6, 2026
Subir ChakrabortyIndependent Director · Since at least Nov 4, 2026

Open People

Log in to ask 6ix AI your own questions about Strides Pharma Science Ltd.